版本:
中国

BRIEF-Avivagen reports positive proof of concept in preventing C. Difficile infection

April 10 Avivagen Inc -

* Avivagen reports positive proof of concept in preventing C. Difficile infection

* Study demonstrated highest dose of OxC-beta technology tested increased survivability in mice versus un-supplemented mouse control group Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐